Buscar
Mostrando ítems 1-10 de 24
Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study
(Pergamon-elsevier Science LtdOxfordInglaterra, 2004)
ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: Correlation with clinical outcomes
(Elsevier Science BvAmsterdamHolanda, 2008)
Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas
(Elsevier Science BvAmsterdamHolanda, 2009)
Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings
(Blackwell PublishingOxfordInglaterra, 2008)
The role of HER2/neu, BCL2, p53 genes and proliferating cell nuclear protein as molecular prognostic parameters in localized prostate carcinoma
(Associação Paulista de Medicina - APM, 2004-05-01)
CONTEXT: Prostate cancer is the most frequent solid genitourinary neoplasm in men. Involvement of several genes has been described in the promotion and progression of prostate carcinoma. OBJECTIVE: To study the expression ...
Expressão do proto-oncogene c-erbB-2(HER-2/neu) no epitélio normal, neoplasia benigna e maligna do ovário
(Universidade Federal de São Paulo (UNIFESP), 2002)
Analisaram-se 75 especimes de ovarios de pacientes atendidas no Departamento de Ginecologia da UNIFESP- EPM, no periodo de julho de 1994 a agosto de 2001. Selecionaram-se 23 (30,66 por cento) pacientes com neoplasia epitelial ...
Estudio de la implicación del oncogen HER2/neu en tumores sólidos
El carcinoma de células renales (CCR) representa el 3% de los tumores del Adulto y el 95% de las neoplasias malignas del riñón. Aproximadamente al 30% de los pacientes que se les practica la resección quirúrgica, desarrollan ...
Protein expression of VEGF, IGF-1 and FGF in retroocular connective tissues and clinical correlation in Graves' ophthalmopathy
(Brasil, 2008)
PURPOSE: To investigate the immunohistochemical expression (IGF-1, EGFr, EGF, c-erbB-2/HER-2/neu, PDGF-A, PDGF-B, FGF and VEGF) in patients with Graves' ophthalmopathy.
METHODS: Twenty-four samples (Graves' ophthalmopathy ...